| scholarly article | Q13442814 |
| P50 | author | Ying Xian | Q39025689 |
| P2093 | author name string | Yun Li | |
| Yong Liu | |||
| Pingyan Chen | |||
| Jiyan Chen | |||
| Ning Tan | |||
| Yingling Zhou | |||
| Chongyang Duan | |||
| Lixia Lin | |||
| Shiqun Chen | |||
| Peng Ran | |||
| Piao Ye | |||
| Dan Lian | |||
| Deng-Xuan Wu | |||
| Yuanhui Liu | |||
| Hualong Li | |||
| Jian-bin Zhao | |||
| P2860 | cites work | Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat. | Q43042095 |
| Development of contrast-induced nephropathy in subarachnoid hemorrhage: a single center perspective | Q43860362 | ||
| Prediction and prevention of contrast nephropathy | Q44020258 | ||
| Assessing glomerular filtration rate (GFR) in elderly Chinese patients with chronic kidney disease (CKD): a comparison of various predictive equations. | Q45926222 | ||
| Contrast nephropathy may be partly mediated by autonomic dysfunction: renal failure considered as a modern maladaptation of the prehistoric trauma response | Q46837214 | ||
| Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography | Q46906389 | ||
| Protective effect of adrenomedullin on contrast induced nephropathy in rats | Q47717057 | ||
| Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents | Q72827801 | ||
| A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation | Q78108694 | ||
| Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease | Q87407572 | ||
| Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty | Q87482858 | ||
| Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature | Q26821942 | ||
| Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial | Q28257023 | ||
| 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa | Q34174388 | ||
| Pathophysiology of contrast medium-induced nephropathy. | Q36162405 | ||
| Contrast-induced acute kidney injury | Q37134762 | ||
| Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines | Q37922124 | ||
| Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. | Q38486291 | ||
| Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy | Q39185275 | ||
| Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial | Q39209066 | ||
| Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification | Q42030454 | ||
| Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. | Q42170160 | ||
| ??? | Q22242895 | ||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contrast-induced nephropathy | Q1783300 |
| P304 | page(s) | e2258 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention | |
| P478 | volume | 94 |
| Q90150705 | A Randomized Double Blind Placebo Controlled Trial Examining the Effects of Pentoxifylline on Contrast Induced Nephropathy Reduction after Percutaneous Coronary Intervention in High Risk Candidates |
| Q64889504 | Simple pre-procedure risk stratification tool for contrast-induced nephropathy. |
Search more.